Galmed Pharmaceuticals Ltd.
Price Action
Technical Summary
WEAKENINGGalmed Pharmaceuticals Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 10), showing significant lag compared to the market leaders. Earnings growth of 70% provides fundamental context to the price action. Investors should exercise caution due to high volatility (86% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.67 | -5.78% | BELOW |
| 50 SMA | $0.62 | +0.79% | ABOVE |
| 100 SMA | $0.70 | -10.02% | BELOW |
| 150 SMA | $0.88 | -28.67% | BELOW |
| 200 SMA | $1.03 | -39.34% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is GLMD in an uptrend right now?
GLMD has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is GLMD overbought or oversold?
GLMD's RSI (14) is 44. The stock is in neutral territory, neither overbought nor oversold.
Is GLMD outperforming the market?
GLMD has a Relative Strength (RS) Rating of 10 out of 99. GLMD is currently lagging the broader market.
Where is GLMD in its 52-week range?
GLMD is trading at $0.63, which is 27% of its 52-week high ($2.34) and 11% above its 52-week low ($0.41).
How volatile is GLMD?
GLMD has a Beta of 1.79 and 52-week volatility of 86%. It's more volatile than the S&P 500 - expect bigger swings.